Crossmark

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors

Crossref DOI link: https://doi.org/10.1186/s12967-018-1452-4

Published Online: 2018-04-02

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gowen, Michael F.

Giles, Keith M.

Simpson, Danny

Tchack, Jeremy

Zhou, Hua

Moran, Una

Dawood, Zarmeena

Pavlick, Anna C.

Hu, Shaohui

Wilson, Melissa A.

Zhong, Hua

Krogsgaard, Michelle

Kirchhoff, Tomas

Osman, Iman https://orcid.org/0000-0002-1472-1971
Funding

Funding for this research was provided by:

NYU Langone Medical Center (P30CA016087)

American Medical Association Foundation

Melanoma Research Foundation

American Skin Association
License Information

Text and Data Mining valid from 2018-04-02
More Information

Article History

Received: 10 January 2018

Accepted: 15 March 2018

First Online: 2 April 2018